Envoy Medical (COCH) Return on Invested Capital (2022 - 2023)

Envoy Medical's (COCH) quarterly Return on Invested Capital came in at 0.0% in Q2 2023, little changed year-on-year from 0.0% in Q2 2022, and little changed quarter-over-quarter from 0.0% in Q1 2023.

Envoy Medical (COCH) Return on Invested Capital (2022 - 2023) Analysis & Trends

Envoy Medical has disclosed Return on Invested Capital across 2 years of filings, most recently posting 0.0% for Q2 2023.

  • Return on Invested Capital for Q2 2023 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 0.0% (changed 0.0% YoY), and the FY2022 annual result was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital came in at 0.0% for Q2 2023 at Envoy Medical, roughly flat from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2022 to a low of 0.0% in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.00%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.00%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.00%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.00%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.00%
10 Envoy Medical 44.81 Mn 19.56 Mn -274,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%